Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Lasa Supergenerics Limited
LASA | NSE
6.24
INR0.29
4.87%
LASA | NSE
Loading StockChartView...
About Lasa Supergenerics Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
02/04/2026
Close
6.24
Open
6.19
High
6.24
Low
5.95
Lasa Supergenerics Limited engages in the research manufacture and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole toldimphos sodium cyromazine albendazole riclabendazole rafoxanide ornidazole ricobendazole oxfendazole closantel base closantel sodium nitroxynil halquinol and oxyclozanide as well as 26-diiodo-4-nitrophenol; and other API products such as anthelmintics. The company also provides animal feed ingredients including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai India.
View LessLASA | NSE
Risk
54.3
Sharpe
-1.24
Luna's Score
51/100
Recommendation
Hold
Luna says (LASA | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
70.0%1 month
54.3%3 months
57.1%6 months
48.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.43
Debt to equity
0.23
Debt to assets
0.15
Ent. to EBITDA
-13.02
Ent. to rev.
1.52
PEG
-
Other Fundamentals
EBITDA
-9.17M
MarketCap
315.52M
MarketCap(USD)
3.40M
Div. yield
-
Op. margin
-3.23
Erngs. growth
224.80
Rev. growth
0.90
Ret. on equity
-20.22
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.01
Range1M
2.63
Range3M
6.81
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.28
Price X volume
88.08K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -13.02 | 24.85 | Cheaper |
| Ent. to Revenue | 1.52 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 1.43 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 57.07 | 42.17 | Riskier |
| Debt to Equity | 0.23 | 0.35 | Cheaper |
| Debt to Assets | 0.15 | 0.17 | Par |
| Market Cap | 315.52M | 290.82B | Emerging |
